Ashleigh SHANNON

Dernières Publications

1. Favipiravir strikes the SARS-CoV-2 at its Achilles heel, the RNA polymerase. (2020)
   Shannon A , Selisko B, Le N, Huchting J, Touret F, Piorkowski G, Fattorini V, Ferron F, Decroly E, Meier C, Coutard B, Peersen O, Canard B
   bioRxiv May 15
2. Drugs against SARS-CoV-2: what do we know about their mode of action? (2020)
   Valle C, Martin B, Touret F, Shannon A , Canard B., Guillemot JC, Coutard B Decroly E.
   Rev Med Virol in press
3. Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites. (2020)
   Shannon A , Tuyet Le NT, Selisko B, Eydoux C, Alvarez K, Guillemot JC, Decroly E, Peersen O, Ferron F, Canard B
   Antiviral Res 178 104793
4. A N7-guanine RNA cap methyltransferase signature-sequence as a genetic marker of large genome, non-mammalian Tobaniviridae. (2020)
   Ferron F, Debat HJ, Shannon A , Decroly E, Canard B
   NAR Genom Bioinform 2 lqz022